Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Perioperative Management

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07567573Completed

Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery

NCT03491033CompletedPrimary

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Showing all 2 trials

Research Network

Common Treatments

  • Perioperative Management1
  • Chemotherapy1
  • Preoperative Evaluations1
  • Systemic Chemotherapy1
  • Cytoreductive Surgery1

Active Sponsors

  • Yonsei University1
  • European Society of Gynaecological Oncology1
  • ESGO Consortium of Accredited Centres1

Top Investigators

Related Conditions

  • Figo Stages Iii And Iv1
  • D0100511
  • Ovarian Cancer1
  • Quality Indicators1

Activity Timeline